FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

53 hedge funds and large institutions have $114M invested in Fate Therapeutics in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.

Holders
53
Holders Change
+16
Holders Change %
+43.24%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
24
Increased
11
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EC
1
EcoR1 Capital
California
$11.5M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.26M
3
6CM
3
683 Capital Management
New York
$2.14M
4
Wells Fargo
4
Wells Fargo
California
$1.28M
5
Millennium Management
5
Millennium Management
New York
$891K

Top Sellers

1
BI
1
BVF Inc
California
$8.85M
2
KCM
2
Kingdon Capital Management
New York
$7.79M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$276K
4
PA
4
Parallel Advisors
California
$0
5
AIM
5
Acrospire Investment Management
Illinois
$40K
Name Market Value Shares Shares
Change 		Shares
Change %
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K 184 – –
PA
52
Parallel Advisors
California
– – -25,000 Closed
HCIA
53
Hochman Cole Investment Advisors
Illinois
– – -10,887 Closed
UBS Group
54
UBS Group
Switzerland
– – -738 Closed
Bank of Montreal
55
Bank of Montreal
Ontario, Canada
– – -13 Closed
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$0 6 +6 New
Citigroup
57
Citigroup
New York
$0 100 +100 New
1 2
3